CCN3 (NOV) Is a Negative Regulator of CCN2 (CTGF) and a Novel Endogenous Inhibitor of the Fibrotic Pathway in an in Vitro Model of Renal DiseaseBruce L. Riser, Sarah C. Riser|American Journal Of Pathology|2009Cited by 111